Industrial Pharmacy
Global Product Development | Key Steps and Common Mistakes
1. Product Identification & Target Market Definition Steps: Common Mistakes: 2. API and Excipient Selection Steps: Common Mistakes: 3. Formulation Development Steps: Common Mistakes: 4. Analytical Development Steps: Common Mistakes: 5. Stability and Compatibility Studies Steps: Common Mistakes: 6. Process Optimization and Scale-Up Steps: Common Mistakes: 7. Bioequivalence and Clinical ... Read More
Multiple Peak Plasma Concentrations (Cmax) of Drugs
There are several potential reasons for multiple peak plasma concentrations. One of which is gut-liver (enterohepatic) recycling (EHR) of drugs. Why is this EHR important for our health? It explains why our gut health (i.e. gut bacteria) can affect drug handling in our body and its treatment (therapeutic) effect. Read ... Read More
Cleaning Validation | FDA vs EMA
I have reviewed 50+ cleaning validation protocols this year. And here is what still surprises me: Most companies treat FDA and EMA requirements as identical twins. They are not. The reality is: Last year, a client passed their FDA pre-approval inspection comfortably. Same facility. Same equipment. Same cleaning procedures. Three ... Read More
Why is Testing into Compliance Prohibited?
“Testing into Compliance” — A Red Flag for FDA Inspectors In pharmaceutical manufacturing, data integrity is non-negotiable. Yet some companies still engage in the risky practice of testing into compliance — retesting until a passing result is found, while ignoring or discarding out-of-specification (OOS) results without proper scientific justification. This ... Read More
Understanding the Inactive Ingredient Guide (IIG)
The Inactive Ingredient Guide (IIG) is a regulatory database published and maintained by the United States Food and Drug Administration (USFDA). It serves as a critical reference for pharmaceutical scientists, formulation developers, and regulatory affairs professionals engaged in the development and approval of drug products—particularly generic drugs submitted through the ... Read More
Selection of Reference Product Across Different Regulatory Markets
Selecting the appropriate reference product is a key step in generic drug development. It serves as the basis for bioequivalence studies and regulatory submissions. The definition and selection criteria for a reference product vary by region, as outlined below. 1. United States (USFDA) – Reference Listed Drug (RLD) The USFDA ... Read More
Is f₂ in Multimedia a True Indicator of Bioequivalence?
The f₂ similarity factor is a commonly used mathematical tool in pharmaceutical development to compare the dissolution profiles of a test product and its reference listed drug (RLD). When the calculated f₂ value is ≥ 50, it indicates that the two profiles are similar under the tested conditions. Regulatory agencies ... Read More
R&D Guide to Dissolution Specification Setting
Setting dissolution specifications at the R&D stage is a critical step in pharmaceutical product development. It ensures that the formulation will consistently meet performance expectations and regulatory requirements. Here’s a clear step-by-step guide: How to Set Dissolution Specifications in R&D 1. Understand the Role of Dissolution Dissolution testing predicts how ... Read More
Anatomy of an FDA Inspection | Part 2 of 2
Winning the Inspection Game – The Habits of Inspection-Ready Companies LIVE THE CULTURE: The entire organization, from top management to line operators, knows that quality isn’t a department—it’s a mindset. It’s part of the air you breathe, the decisions you make. Follow SOPs consistently, encourage employees to report and fix ... Read More
Anatomy of an FDA Inspection | Part 1 of 2
Inspections are how the FDA checks that what’s promised is real: FDA inspections can occur for various reasons – a routine schedule, a follow-up to a prior issue, a pre-approval for a new product, or “for-cause” in response to a specific problem. What Happens During an FDA Inspection? (And What ... Read More
Blister Pack vs. Bottle | The Real Reason Behind Packaging Choices
Ever wondered why some medicines come in blisters while others are in bottles? It’s not just about cost or convenience—there’s a lot more behind these decisions! 1. RLD (Reference Listed Drug) – The Hidden Decision Maker When a generic drug is developed, it must match the Reference Listed Drug (RLD), ... Read More